CD23 expression in plasma cell myeloma is specific for abnormalities of chromosome 11, and is associated with primary plasma cell leukaemia in this cytogenetic sub-group

British Journal of Haematology

Volumn 149, Issue 2, 2010, Pages 292-293

  Walters, Matthew ^a   Olteanu, Horatiu ^a   Van Tuinen, Peter ^a   Kroft, Steven H ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

CD23; Cyclin; Fluorescent in situ hybridization; Myeloma; Plasma cell leukaemia

Indexed keywords

CD20 ANTIGEN; CD23 ANTIGEN; CD45 ANTIGEN; CD56 ANTIGEN; CYCLIN D1;

BONE MARROW BIOPSY; CHROMOSOME 11; CHROMOSOME ANALYSIS; HUMAN; IMMUNOPHENOTYPING; LETTER; MULTIPLE MYELOMA; PLASMA CELL LEUKEMIA; PRIORITY JOURNAL;

EID: 77949820545     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.08042.x     Document Type: Letter

References (10)

1. Avet-Loiseau, H., Attal, M., Moreau, P., Charbonnel, C., Garban, F., Hulin, C., Leyvraz, S., Michallet, M., Yakoub-Agha, I., Garderet, L., Marit, G., Michaux, L., Voillat, L., Renaud, M., Grosbois, B., Guillerm, G., Benboubker, L., Monconduit, M., Thieblemont, C., Casassus, P., Caillot, D., Stoppa, A.M., Sotto, J.J., Wetterwald, M., Dumontet, C., Fuzibet, J.G., Azais, I., Dorvaux, V., Zandecki, M., Bataille, R., Minvielle, S., Harousseau, J.L., Facon, T. Mathiot, C. (2007) Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome. Blood, 97, 3489 3495.
2. Bergsagel, P.L., Kuehl, W.M., Zhan, F., Sawyer, J., Barlogie, B. Shaughnessy, Jr., J. (2005) Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma. Blood, 106, 296 303.
3. Garcia-Sanz, R., Orfao, A., Gonzalez, M., Tabernero, M.D., Blade, J., Moro, M.J., Fernandez-Calvo, J., Sanz, M.A., Perez-Simon, J.A., Rasillo, A. Miguel, J.F. (1999) Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics. Blood, 93, 1032 1037.
4. Harrington, A.M., Hari, P. Kroft, S.H. (2009) Utility of CD56 Immunohistochemical studies in follow-up of plasma cell myeloma. American Journal of Clinical Pathology, 132, 60 66.
5. Heerema, N.A., Raimondi, S.C., Shuster, J., Biegel, C., Cooley, L.D., Gaynon, P., Hirsch, B., Magenis, H.E., McGavran, L., Patil, S., Pettenati, M.J., Pullen, J., Rao, K., Schneider, N.R., Roulston, D., Sanger, W., Sather, H.N., Sutcliffe, M.J., Van Tuinen, P., Watson, M.S. Carroll, A.J. (2007) Extra copy numbers of specific chromosomes occur in an identifiable pattern at each modal number and are cumulative in pediatric acute lymphoblastic leukemia. Genes, Chromosomes and Cancer, 46, 684 693.
6. Hibbert, R.G., Teriete, P., Grundy, G.J., Beavil, R.L., Reljic, R., Holers, V.M., Hannan, J.P., Sutton, B.J., Gould, H.J. McDonnell, J.M. (2005) The structure of human CD23 and its interactions with IgE and CD21. Journal of Experimental Medicine, 202, 751 760.
7. Hundemer, M., Klein, U., Hose, D., Raab, M.S., Cremer, F.W., Jauch, A., Benner, A., Heiss, C., Moos, M., Ho, A.D. Goldschmidt, H. (2007) Lack of CD56 expression on myeloma cells is not a marker for poor prognosis in patients treated by high-dose chemotherapy and is associated with translocation t(11;14). Bone Marrow Transplantation, 40, 1033 1037.
8. Lin, P., Owens, R., Tricot, G. Wilson, C.S. (2004) Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma. American Journal of Clinical Pathology, 121, 482 488.
9. McKenna, R.W., Kyle, R.A., Kuehl, W.M., Grogan, T.M., Harris, N.L. Coupland, R.W. (2008) Plasma cell neoplasms. In : WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues (ed. by S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stein, J. Thiele J.W. Vardiman pp. 200 213. IARC, Lyon.
10. Pathan, N.I., Chu, P., Hariharan, K., Cheney, C., Molina, A. Byrd, J. (2008) Mediation of apoptosis by and antitumor activity of lumiliximab in chronic lymphocytic leukemia cells and CD23+ lymphoma cell lines. Blood, 111, 1594 1602.